Search research articles
Contact Us
Filters
Showing results (181-190 of 344) with videos related to
Page
of 35
Sort By:
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
July 24, 2020
A multicenter phase II study of TAS-114 in combination with S-1 in patients with pretreated advanced gastric cancer (EPOC1604)
Akihito Kawazoe, Daisuke Takahari, Chin Keisho, et al.
Clinical Pharmacokinetics
|
August 14, 2025
Clinical Pharmacology Profile of the Claudin 18.2 Antibody Zolbetuximab
Jianning Yang, Akihiro Yamada, Kohei Shitara, et al.
Cancer Science
|
August 23, 2011
Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population
Daisuke Ennishi, Kohei Shitara, Hidemi Ito, et al.
International Journal of Clinical Oncology
|
June 17, 2022
Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors
Yu Aoki, Akihito Kawazoe, Yohei Kubota, et al.
ESMO Open
|
November 15, 2018
Efficacy and safety of ramucirumab-containing chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma
Saori Mishima, Akihito Kawazoe, Hiroshi Matsumoto, et al.
JAMA Oncology
|
August 25, 2022
Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer: Systematic Review and Meta-analysis of 17 Phase 3 Randomized Clinical Trials
Harry H Yoon, Zhaohui Jin, Oudom Kour, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
February 3, 2017
Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG
Kozo Kataoka, Takahiro Kinoshita, Markus Moehler, et al.
Cancer Science
|
July 25, 2018
Dose-finding study of the checkpoint kinase 1 inhibitor, prexasertib, in Japanese patients with advanced solid tumors
Satoru Iwasa, Noboru Yamamoto, Kohei Shitara, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
February 10, 2020
Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G)
Takako Eguchi Nakajima, Kensei Yamaguchi, Narikazu Boku, et al.
Journal for Immunotherapy of Cancer
|
August 16, 2019
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors
Kohei Shitara, Taroh Satoh, Satoru Iwasa, et al.
Page
of 35
Search research articles
Search
Showing results (181-190 of 344) with videos related to
Sort By:
Page
of 35
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
July 24, 2020
A multicenter phase II study of TAS-114 in combination with S-1 in patients with pretreated advanced gastric cancer (EPOC1604)
Akihito Kawazoe, Daisuke Takahari, Chin Keisho, et al.
Clinical Pharmacokinetics
|
August 14, 2025
Clinical Pharmacology Profile of the Claudin 18.2 Antibody Zolbetuximab
Jianning Yang, Akihiro Yamada, Kohei Shitara, et al.
Cancer Science
|
August 23, 2011
Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population
Daisuke Ennishi, Kohei Shitara, Hidemi Ito, et al.
International Journal of Clinical Oncology
|
June 17, 2022
Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors
Yu Aoki, Akihito Kawazoe, Yohei Kubota, et al.
ESMO Open
|
November 15, 2018
Efficacy and safety of ramucirumab-containing chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma
Saori Mishima, Akihito Kawazoe, Hiroshi Matsumoto, et al.
JAMA Oncology
|
August 25, 2022
Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer: Systematic Review and Meta-analysis of 17 Phase 3 Randomized Clinical Trials
Harry H Yoon, Zhaohui Jin, Oudom Kour, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
February 3, 2017
Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG
Kozo Kataoka, Takahiro Kinoshita, Markus Moehler, et al.
Cancer Science
|
July 25, 2018
Dose-finding study of the checkpoint kinase 1 inhibitor, prexasertib, in Japanese patients with advanced solid tumors
Satoru Iwasa, Noboru Yamamoto, Kohei Shitara, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
February 10, 2020
Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G)
Takako Eguchi Nakajima, Kensei Yamaguchi, Narikazu Boku, et al.
Journal for Immunotherapy of Cancer
|
August 16, 2019
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors
Kohei Shitara, Taroh Satoh, Satoru Iwasa, et al.
Page
of 35